Finerenone for chronic kidney disease in type 2 diabetes
Description
In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Angela Newbound
Practical Strategies to Increase Vaccination Rates This Flu Season
Prof Andrew Sindone AM
MRAs for Heart Failure Update - New Developments
A/Prof Ralph Audehm & Prof Simone Strasser
Abnormal LFTs – Practical Cases Expert Q&A
Prof David Price
COPD Exacerbation – Inhaled steroids vs Pneumonia Risks – It's Not Black and White
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Nephrologist; Program Lead, Cardiometabolic Trials, Renal and Metabolic Program, The George Institute for Global Health; Senior Staff Specialist Nephrologist, St George Hospital
